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Introduction
Abs with high affinity for antigen (Ag) are produced by B cells that are selected in the germinal center (GC) 
reaction (1–3). T follicular helper (TFH) cells are critical for this selection process (1–3). TFH cells provide 
survival and proliferative signals to GC B cells via CD40 ligand as well as the secretion of  key cytokines 
such as IL-4 and IL-10 (1–3). Ab responses are also modulated by T follicular regulatory (TFR) cells, a 
subset of  Foxp3+ regulatory T cells that express CXCR5 and localize to the GC (4–6). Both TFR cells and 
TFH cells are dependent on the transcriptional repressor protein Bcl6 for their development (3–7). TFR 
cells are derived from Foxp3+ regulatory T (Treg) cells and have been reported to repress excessive TFH cell 
and GC B cell proliferation as well as promote the selection of  high-affinity B cells (8–11). The suppressor 
mechanisms used by TFR cells to suppress the GC are not well defined. Furthermore, a few recent studies 
have challenged the suppressor model of  TFR cell function (reviewed in ref. 9).
A mouse model in which the Bcl6 gene is specifically deleted in Foxp3+ T cells (Bcl6-flox Foxp3-Cre, or 
Bcl6FC mice), blocking TFR cell development, has been used to precisely target TFR cell development in 
vivo (7, 12–14). This Bcl6FC mouse model has helped to show that TFR cells can help promote the Ag-spe-
cific IgG and GC response, in part by expressing the cytokine IL-10, which can promote GC B cell growth 
(7, 12). However, the full functions of  TFR cells in the GC remain unclear and particularly it is unknown 
if  TFR cells use other mechanisms besides IL-10 to help augment GC B cell responses and Ab production. 
Here we examined TFH cell gene expression in TFR cell–deficient and TFR cell–amplified mouse strains 
and we find that TFR cells are critical for inhibiting the development of  an aberrant TFH cell subset with 
cytotoxic potential. Our data show that TFR cells control TFH gene expression and point to a mechanism 
for how TFR cells can promote the GC and Ab response. Our findings also raise the intriguing prospect 
that TFH cells can control the GC and Ab response by a cytotoxic mechanism.
T follicular regulatory (TFR) cells are found in the germinal center (GC) response and help shape the 
antibody (Ab) response. However, the precise role of TFR cells in the GC is controversial. Here, we 
addressed TFR cell function using mice with impaired TFR cell development (Bcl6-flox/Foxp3-cre, 
or Bcl6FC mice), mice with augmented TFR cell development (Blimp1-flox/Foxp3-cre, or Blimp1FC 
mice), and two different methods of immunization. Unexpectedly, GC B cell levels positively 
correlated with TFR cell levels. Using a gene profiling approach, we found that TFH cells from TFR-
deficient mice showed strong upregulation of granzyme B (Gzmb) and other effector CD8+ T cell 
genes, many of which were Stat4 dependent. The upregulation of cytotoxic genes was the highest 
in TFH cells from TFR-deficient mice where Blimp1 was also deleted in Foxp3+ regulatory T cells 
(Bcl6-flox/Prdm1-flox/Foxp3-cre [DKO] mice). Granzyme B– and Eomesodermin-expressing TFH 
cells correlated with a higher rate of apoptotic GC B cells. Klrg1+ TFH cells from DKO mice expressed 
higher levels of Gzmb. Our data show that TFR cells repress the development of abnormal cytotoxic 
TFH cells, and the presence of cytotoxic TFH cells correlates with a lower GC and Ab response. Our 
data show what we believe is a novel mechanism of action for TFR cells helping the GC response.
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Results
TFR cells promote stronger GC B cell and IgE responses. To study Ag-specific Ab responses, we used a classic 
model of  food allergy induced by challenge intragastrically (i.g.) with peanut protein plus cholera toxin 
(PCT) (15). In this model, high levels of  peanut-specific IgE are induced and maintained in circulation for 
weeks after immunization in normal mice. To test the role of  TFR cells, we used 3 conditional knockout 
strains with altered TFR cell development: “Bcl6FC” mice with Bcl6 deletion in Foxp3+ cells and so lack 
TFR cells (7), “Blimp1FC” mice with Prdm1 (Blimp1) deletion in Foxp3+ cells leading to augmented TFR 
cells (16), and “DKO” mice with deletion of  both Bcl6 and Prdm1 in Foxp3+ cells. All of  these mouse strains 
were grossly healthy with no obvious disease up to 10 weeks of  age. As shown in Figure 1A, TFR cells were 
largely ablated in Bcl6FC and DKO mice but were increased about 2-fold over WT levels in Blimp1FC 
mice, similar to previously reported observations (16). The lack of  TFR cells in DKO mice shows that Bcl6 
has a dominant role in promoting TFR cell development over repression by Blimp1. Loss of  TFR cells did 
not affect TFH cell numbers in Bcl6FC mice; however, there was a marked increase in both Blimp1FC and 
DKO TFH cells (Figure 1B). Blimp1 is required for IL-10 expression by Tregs (17), indicating that Tregs 
from both Blimp1FC and DKO mice are defective in IL-10 expression. Therefore, the data in Figure 1B 
suggest that, more than TFR cells, Treg-derived IL-10 controls the expansion of  TFH cells. In contrast, GC 
B cell numbers showed a clear positive correlation with TFR cells in the 4 mouse strains (Figure 1C). There 
was a 5- to 6-fold lower ratio of  GC B cells to TFH cells in TFR-deficient mice compared with TFR-suffi-
cient mice, indicating that TFR cells increase the helper function of  TFH cells in the GC (Figure 1, D and 
E). Analysis of  peanut-specific Ab titers revealed that TFR cells were also required for sustained and robust 
peanut-specific IgE and IgG1 responses in this model (Figure 1F). Overall, these findings support the idea 
that TFR cells act as helper cells in the GC and promote the Ag-specific IgE response.
TFR cells inhibit the development of  aberrant cytotoxic gene–expressing TFH cells, particularly in the context 
of  an inflammatory environment. To better understand how TFR cells were influencing the ability of  TFH 
cells to help GC B cells, we used RNA sequencing (RNAseq) to profile gene expression in TFH cells from 
PCT-challenged WT, Bcl6FC, Blimp1FC, and DKO mice (Figure 2 and Supplemental Figure 2A; sup-
plemental material available online with this article; https://doi.org/10.1172/jci.insight.128076DS1). 
TFH gene expression was strongly affected by loss of  TFR cells, leading to several hundred up- and 
downregulated differentially expressed genes (DEGs) for both Bcl6FC and DKO TFH cells (Figure 2A). 
Gzmb (granzyme B), a gene associated with cytotoxic T cells, stood out as being strongly elevated in TFH 
cells from both Bcl6FC and DKO mice, strains both lacking TFR cells (Figure 2A). Compared with WT 
TFH cells, Gzmb was increased 9-fold in Bcl6FC TFH cells and increased 66-fold in DKO TFH cells. 
Comparing DKO TFH cells to Blimp1FC TFH cells, Gzmb was increased 173-fold in DKO TFH cells. 
Despite the high number of  DEGs, the expression of  key TFH genes was essentially normal in Bcl6FC 
and DKO TFH cells (Figure 2B). To better understand the nature of  the DEGs in Bcl6FC and DKO TFH 
cells, we compared upregulated DEGs from our data set with published gene expression data sets. We 
found a highly significant enrichment of  genes that were at least 2-fold upregulated in effector CD8+ T 
cells (18) or more than 2-fold downregulated in Stat4–/– Th1 cells (19) within the upregulated DEGs from 
Bcl6FC and DKO TFH cells (Figure 2C and Supplemental Figure 1). Next, we selected a set of  23 genes 
cells that were highly upregulated in Bcl6FC and DKO TFH and also associated with CD8+ effector T 
cell differentiation (refs. 18, 20, and Figure 2D). About two-thirds (15 of  23) of  these genes were both 
upregulated during CD8+ effector T cell differentiation (Figure 2E) and also positively regulated by Stat4 
(Figure 2F). Unexpectedly, the expression of  the CD8+ effector genes was nearly identical between WT 
and Blimp1FC TFH cells, even though Blimp1FC mice have defective Treg cell function and develop 
inflammatory disease (21, 22). CD8+ cytotoxic effector genes were upregulated to a higher degree in 
DKO TFH cells than in Bcl6FC TFH cells (Figure 2, C and D), indicating that loss of  TFR cells together 
with loss of  Blimp1 in Tregs in the DKO mice promoted a synergistic loss of  control in TFH cell differen-
tiation. Blimp1FC and DKO Tregs cannot produce IL-10 due to Blimp1 deficiency and DKO Tregs can-
not develop into TFR cells due to Bcl6 deficiency. The deficiency of  Treg-derived IL-10 could lead to an 
inflammatory environment in vivo that contributes to the greatly increased development of  cytotoxic-like 
TFH cells in DKO mice. Additionally, despite significant overlap of  the cytotoxic T cell gene program 
with Stat4 function, the cytotoxic gene program appeared to be a unique non-Th1 differentiation state, 
as there were no significant increases in Ifng and Txb21 (Tbet) (Figure 3A), nor was there an enrichment 
of  Tbet target genes in the cytotoxic TFH genes from Bcl6FC and DKO mice (Figure 3B). We then 
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Figure 1. TFR cells are required for proper GC B cell 
numbers in a food allergy immune response. WT, 
Bcl6FC, Blimp1FC, and DKO mice were orally immunized 
twice with peanut protein plus cholera toxin (PCT). 
Four weeks after the last PCT immunization (day 36), 
spleens (SP) were analyzed for the indicated cell popu-
lations by flow cytometry. Representative contour dot 
plots for each cell staining are shown along with graphs 
showing average percentage of cells as a fraction of 
parental cell population. (A) Analysis of CD4+FOX-
P3+PD-1+CXCR5+ TFR cells. Average TFR cells per group 
are quantitated as a percentage (%) of FOXP3+CD4+ 
T cells, and absolute number (#). (B) Analysis of 
CD4+FOXP3–PD-1+CXCR5+ TFH cells. Average TFH cells 
are quantitated as a percentage of FOXP3–CD4+ T cells, 
and absolute number. (C) Analysis of B220+CD38–GL7+ 
GC B cells. Average GC B cells per group graphed as a 
percentage of B220+ cells and as absolute number. (D 
and E) Ratio of GC B cells to TFH cells from data in A–C. 
(F) Titers of peanut-specific IgE and IgG1 by ELISA at 
day 36. Graphs show the mean ± SEM. P values were 
calculated by t test, where *P < 0.05, **P < 0.01, ***P < 
0.0001. n = 4–6 mice. Data shown are representative of 
3 experiments with similar results. ANOVA with Tukey’s 
post hoc analysis was used to determine statistical 
significance.
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wondered if  cytotoxic TFH cells might develop in a natural context such as inflammation during virus 
infection. Using an RNAseq data set of  TFH cells from simian immunodeficiency virus–infected (SIV-in-
fected) macaques (23), we observed that there was a small but highly significant increase in expression of  
the 23 CD8 effector cytotoxic genes in SIV+ versus SIV– TFH cells (Figure 3C).
Cytotoxic gene expression in TFH cells and increased GCB apoptosis in TFR-deficient mice. To better character-
ize Gzmb-expressing cytotoxic-like TFH cells, we immunized WT, Bcl6FC, Blimp1FC, and DKO mice with 
sheep red blood cells (SRBCs), a model Ag that induces strong TFH responses. We stained TFH cells intracel-
lularly for granzyme B protein by flow cytometry and saw a clearly distinct population of  granzyme B+ cells 
in DKO TFH cells that was not seen in the other types of  TFH cells (Figure 4A). This finding was consistent 
with the higher level of  CD8 effector gene upregulation in DKO TFH cells (Figure 2). We next examined 
Eomesodermin (Eomes), a protein highly expressed in CD8+ effector T cells and cytotoxic CD4+ T cells (24). 
DKO TFH cells also had a clear population of  Eomes+ TFH cells that was not observed in the other TFH cell 
types (Figure 4B). Costaining for both granzyme B and Eomes showed that all granzyme B+ cells expressed 
Eomes, whereas there was a subset of  Eomes+ cells that did not express granzyme B (Figure 4C). We also 
detected a well-defined population of  DKO TFH cells expressing cell surface Klrg1 (Figure 5A). We therefore 
isolated Klrg1+ TFH cells by FACS to test gene expression compared to Klrg1– TFH cells (Figure 5B). Klrg1+ 
DKO TFH cells had increased Gzmb mRNA and lower expression of  the TFH genes Bcl6, Il4, and Il21, where-
as Eomes, Ifng, and Prdm1 were not significantly different between the two populations (Figure 5B). Klrg1+G-
zmb+ DKO TFH cells likely have decreased helper potential due to lower Il4 and Il21, concurrent with a 
cytotoxic genotype. Similar to our results with PCT immunization, GC B cell responses were sharply lower 
in TFR-deficient mice after SRBC immunization (Figure 6, A–C). We then reasoned that cytotoxic TFH cells 
might kill GC B cells, leading to the losses of  GC B cells seen in TFR-deficient mice. Analyzing cells directly 
ex vivo we observed a significant increase in apoptotic GC B cells in Bcl6FC and DKO mice compared with 
WT and Blimp1FC levels (Figure 6D). DKO GC B cells showed a 3-fold increase in apoptotic cells over 
Blimp1FC GC B cells, compared with a 2-fold increase in Bcl6FC apoptotic GCB cells over WT GC B cells. 
This higher level of  apoptosis is consistent with a higher level of  cytotoxic TFH cells in DKO mice.
Discussion
In this study, we define a cytotoxic-like TFH cell subset that is repressed by TFR cells and is promoted by 
proinflammatory signals (virus infection, loss of  Treg cell function). These cytotoxic-like TFH cells express 
high levels of  granzyme B and Eomes proteins and express several other genes associated with CD8+ cyto-
toxic T cell function. Since the main function of  TFH cells is to interact with B cells in the GC, cytotox-
ic-like TFH cells have the potential to kill B cells in the GC. Our findings therefore open up a possible new 
regulatory pathway for the GC and high-affinity Ab production. Additionally, TFR cells have been gener-
ally considered to repress the GC and Ab response (8–11). However, a recent study showed that TFR cells 
expressing IL-10 can act as helpers and promote Ag-specific IgG production and the GC response (12). 
Our data in this study show a potent helper effect of  TFR cells on the GC that correlates with suppressed 
development of  cytotoxic-like TFH cells. As shown in Supplemental Figure 2, injection of  WT Tregs capa-
ble of  developing into TFR cells into DKO mice repressed the abnormal production of  cytotoxic-like TFH 
cells. Thus, TFR cells actively regulate the differentiation of  TFH cells into different functional phenotypes. 
Furthermore, we have revealed what we believe is a new mechanism of  TFR cell help in the GC response: 
inhibiting the development of  cytotoxic-like TFH cells.
Figure 2. TFR cells repress a cytotoxic gene program in TFH cells. WT, Bcl6FC, Blimp1FC, and DKO mice were immunized twice with PCT (n = 4). Four 
weeks after the last immunization, TFH cells were isolated by FACS, RNA was then prepared and subjected to RNAseq. (A) Volcano plots showing differ-
entially expressed genes (DEGs) for Bcl6FC versus WT (155 genes up, 410 genes down) and DKO versus Blimp1FC (517 genes up, 1041 down). Blue indicates 
downregulated genes and purple upregulated genes, using FDR < 0.05 after multiple-test correction and fold change (FC) < –1.8 or > 1.8 (linear). Gzmb is 
specifically marked in both plots. Gzmb is increased 9-fold in Bcl6FC TFH cells compared with WT TFH cells, and Gzmb is increased 173-fold in DKO TFH 
cells compared with Blimp1FC TFH cells. (B) Heatmap showing expression assessed with RNAseq of 21 hallmark TFH genes sorted alphabetically. Color 
scale shows log2RPKM of gene expression. (C) Fraction of genes associated with CD8 (left panel) or Stat4 (right panel) in all TFH expressed genes (gray 
bar), TFH DEGs upregulated for Bcl6FC (purple bar), or DKO (brown bar) versus WT. The CD8 or Stat4 genes were acquired from published data sets for 
DEGs in effector CD8 differentiation (18) and Stat4 regulation in Th1 cells (19). The P values were calculated based on hypergeometric distribution, repre-
senting statistical significance of enrichment of CD8 and Stat4 genes in Bcl6FC or DKO upregulated DEGs compared with the occurrence in all expressed 
TFH genes. (D–F) A set of 23 genes was used to create heatmaps based on log2RPKM gene expression for (D) WT, Bcl6FC, Blimp1FC, and DKO TFH cells; 
(E) naive and effector CD8+ T cells (18); and (F) WT and Stat4–/– Th1 cells (19). In E and F, FCs for the paired sets of genes are shown by a single-column 
heatmap. See Methods for statistical analysis of gene data sets.
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Our analysis of  TFH cells from SIV-infected macaques indicates that the cytotoxic-like TFH cell phe-
notype that develops in the absence of  TFR cells can also develop in a normal (TFR cell sufficient) GC 
response after virus infection. Granzyme B–expressing circulating TFH cells have been found in humans, 
and the development of  this population is Stat3 dependent (25). However, we were unable to find an enrich-
ment of  Stat3 target genes in our TFH cell data (data not shown), suggesting there may be different origins 
for these circulating granzyme B–expressing TFH cells. Here, we saw a strong correlation of  TFH cytotoxic 
genes with Stat4 transcriptional function. Higher Stat4 activity may indicate that IL-12 is increased in the 
GC environment in the absence of  TFR cells. One key function of  Tregs is to downmodulate dendritic cell 
function, including the secretion of  cytokines such as IL-12 (26, 27). Like Tregs, TFR cells may function to 
suppress dendritic cells, but act in the GC and/or B cell follicle.
Very recently, granzyme B–expressing TFH cells have been found in GCs in human tonsillitis (28). 
How these human cytotoxic TFH cells develop is not clear, but they appear to be a defective or exhausted 
state of  TFH cell differentiation induced by chronic infection (28). It is tempting to speculate that defective 
TFR cell function leads to the development of  these human granzyme B–expressing TFH cells, but more 
research is required for answering this question. However, our results show that this cytotoxic TFH cell 
Figure 3. Expression of Th1 genes in TFH cells, Tbet regulation of cytotoxic genes, and cytotoxic TFH genes upregulated after SIV infection. (A) Gene 
expression plots for Ifng, Tbx21 (Tbet), and Prdm1 (Blimp1) taken from the RNAseq data analyzed in Figure 2. WT (red) TFH cell average mRNA levels were 
set to 1 and fold changes are shown for Bcl6FC (blue), Blimp1FC (green), and DKO (magenta) TFH cells. The mRNA levels are taken from log2RPKM counts. 
n = 4. ANOVA with Tukey’s post hoc analysis was used to determine statistical significance. (B) Heatmap of the gene set of 23 CD8+ cytotoxic T cell genes 
described in Figure 2, D–F, versus published gene expression data for WT and Tbet-KO T cells (GSE105806). (C) Comparison of fold changes in genes from 
TFH cells from SIV+ infected macaques over uninfected TFH cells from uninfected macaques (published RNAseq data GSE69756). As a group, the 23 CD8+ 
cytotoxic T cell genes described in Figure 2, D–F, show a statistically significant increase within the SIV+ TFH RNAseq data set over the SIV– TFH RNA-
seq data set (“cytotoxic” column), in comparison with all other noncytotoxic genes expressed in the TFH cells, which on average showed no statistically 
significant upregulation between the 2 types of TFH cells (“other” column). For statistical significance of overlap between 2 sets of genes, the P value was 
calculated based on hypergeometric distribution.
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pathway is conserved between mouse and humans and increases the possibility that TFR cells also control 
the development of  human granzyme B–expressing TFH cells.
Overall, our findings raise the possibility that cytotoxic TFH cells are a normal part of  the GC response 
and that granzyme B+ TFH cells kill GC B cells. These cytotoxic-like TFH cells not only suppress the Ab 
response, as in the case of  PCT immunization, but can fine-tune the types of  IgG isotypes within the Ab 
response as shown with SRBC immunization (Supplemental Figure 3). Increased cytotoxic TFH cells in 
DKO mice correlated with a significant shift from in the ratio of  IgG1 to IgG2b anti-SRBC Ab (Supple-
mental Figure 3). Cytotoxic TFH cells may also play a role in controlling virus infection in the GC, as we 
observed higher levels of  cytotoxic genes in TFH cells after SIV infection. Augmenting the development of  
these aberrant TFH cells may be beneficial after virus infection. Cytotoxic CD4+ T cells have been studied 
previously by many investigators, but were never identified as a TFH cell subset (24). How TFR cells sup-
press granzyme B–expressing TFH cells and the precise function of  granzyme B–expressing TFH cells will 
be important areas for future research.
Figure 4. Cytotoxic gene expression in TFH cells and increased GC B cell apoptosis in TFR-deficient mice. Cytotoxic gene expression in TFH cells and 
increased GCB apoptosis in TFR-deficient mice. WT, Bcl6FC, Blimp1FC, and DKO mice were immunized with SRBCs and 9 days later, spleen cells were analyzed 
by flow cytometry for CD4+FOXP3–PD-1+CXCR5+ TFH cells and staining with (A) anti–granzyme B (Gzmb) Ab, (B) anti-Eomesodermin (Eomes) Ab, or (C) both 
Gzmb and Eomes Abs. Average Gzmb+ (A), Eomes+ (B), and Gzmb+Eomes+ (C) TFH cells are quantitated and graphed as a percentage of TFH cells, and absolute 
number. A total of 100,000 cells were analyzed by flow cytometry and TFH cells (0.5%–3%, 500–3,000) were gated for further analysis. n = 4; experiment was 
repeated 3 times. ANOVA with Tukey’s post hoc analysis was used to determine statistical significance.
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Methods
Mice. Foxp3-Yfp-cre only (WT) and Foxp3-Yfp-cre Bcl6-flox (Bcl6FC) mice were previously described (7, 
29). Prdm1-flox mice (30) were crossed with Bcl6FC transgenic mice to generate Foxp3-Yfp-cre Prdm1-flox 
(Blimp1FC) and Foxp3-YFP-cre Prdm1-flox Bcl6-flox (DKO) mice. Male and female mice 6–10 weeks old 
were used. Mice were bred under specific pathogen–free conditions at the laboratory animal facility at 
Indiana University School of  Medicine (IUSM).
Immunizations. On days 1 and 8, food was withdrawn from mice for 2 hours followed by gavage of  300 μL 
per mouse with 1.5% NaHCO3 in water i.g. One hour later, mice were orally immunized i.g. with 1 mg per 
mouse of  peanut extract (Greer Laboratories) together with 10 μg per mouse of  cholera toxin (Sigma-Aldrich) 
(15). For SRBC immunization, mice were injected i.p. with 1 × 109 SRBCs (Rockland Immunochemicals). 
Mice were sacrificed on indicated days and serum, mesenteric lymph nodes, and spleens were harvested.
Figure 5. Cytotoxic gene expression is enriched in Klrg1+ TFH cells. WT, 
Bcl6FC, Blimp1FC, and DKO mice were immunized with SRBCs and spleens 
were analyzed for Klrg1 on TFH cell populations by flow cytometry. (A) Anal-
ysis of CD4+FOXP3–PD-1+CXCR5+ TFH cells for Klrg1 expression 9 days after 
immunization. Average Klrg1+ TFH cells are quantitated and graphed as a 
percentage of TFH cells, and absolute number. n = 4; experiment was repeat-
ed 3 times. Cells (100,000 total) were analyzed by flow cytometry and TFH 
cells (0.5%–3%, 500–3,000) were gated for further analysis. ANOVA with 
Tukey’s post hoc analysis was used to test for significant differences. (B) TFH 
cells from 4 DKO mice (n = 3) were separated into Klrg1+ and Klrg– populations 
by FACS, and RNA was prepared directly after sorting. RT-qPCR was used to 
analyze gene expression in Klrg1+ and Klrg1– TFH cells. Graphs show relative 
expression for the indicated genes with the mRNA level in Klrg1– cells set to 
1. This experiment was done twice with similar results. Approximately 15,000 
Klrg1+ and approximately 500,000 Klrg1– TFH cells were sorted per mouse. 
Student’s t test was used to detect significant differences.
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Flow cytometry. Cell suspensions were filtered through 
a 40-μm cell strainer (Fisherbrand). Cells were washed and 
diluted in PBS with 1% FBS and were stained with Fc block 
(BioXCell) for 5 minutes, followed by surface staining for 
the indicated markers. The following labeled Abs were 
used: anti-CXCR5 (L138D7), anti–PD-1 (29F.1A12), anti-
CD4 (RM4-5), anti-FOXP3 (MF-14), anti-CD38 (90), and 
anti-B220 (RA3-6B2) were obtained from BioLegend; anti-
GL7 (GL7) Ab was purchased from BD Pharmingen. Anti–
annexin V Ab was obtained from BioLegend. For intra-
cellular staining, after surface markers were stained, cells 
were fixed and stained with anti–granzyme B (GB11) and 
anti-Eomes (Dan11mag) using an eBioscience intracellular 
kit. All samples were acquired on an LSR2 flow cytometer 
(Becton Dickinson) and analyzed with FlowJo software.
Ab measurement. Titers of  peanut-specific Ab in serum were measured by ELISA, as previously report-
ed (31). For peanut-specific IgE, 96-well Nunc-Immuno plates (Sigma-Aldrich) were coated with IgE Ab 
(LO-ME-3, Bio-Rad) overnight at 4°C. Wells were blocked with 1% BSA and diluted serum was added and 
incubated at room temperature for 2 hours. Peanut extract protein was labeled with biotin (Sigma-Aldrich) 
and added for 1 hour followed by adding poly-HRP streptavidin (Pierce Endogen) for 30 minutes.
Cell sorting, RNA isolation, and gene expression analysis. On day 36 after PCT challenge, CD4+ T cells were 
isolated from the spleen from mice using a CD4 T cell Macs isolation kit (Miltenyi Biotec). Cells were 
stained for CD4, CXCR5, and PD-1, and TFH cells were isolated by FACS. For isolation of  Klrg1+ cells, 
mice were immunized with SRBC and TFH cells sorted as above but anti-Klrg1 Ab (2F1/KLRG1, BioLeg-
end) was also used for staining. Total RNA was collected from freshly sorted cells using the RNeasy Plus 
Micro kit (QIAGEN). qPCR reactions were performed as previously reported (32).
RNAseq and bioinformatics analysis. RNAseq was performed by the IUSM Center for Molecular Genom-
ics. KAPA mRNA HyperPrep methods were used for mRNA sequencing. Total RNA was evaluated for its 
quantity and quality using an Agilent Bioanalyzer 2100. For RNA quality, a RIN number of  7 or higher 
was used. Fifty nanograms of  total RNA was used. cDNA library preparation included mRNA purifi-
cation/enrichment, RNA fragmentation, cDNA synthesis, ligation of  index adaptors, and amplification, 
following the KAPA mRNA Hyper Prep Kit Technical Data Sheet, KR1352 – v4.17 (Roche Corporate). 
Each resulting indexed library was quantified and quality accessed by Qubit and Agilent Bioanalyzer. Mul-
tiple libraries were pooled in equal molarity. Five microliters of  2-nM pooled libraries per lane were dena-
tured, neutralized, and applied to the cBot for flow cell deposition and cluster amplification, before loading 
onto the HiSeq 4000 for 75-bp paired-end sequencing (Illumina, Inc.). Approximately 30 million reads per 
library were generated. A Phred quality score (Q score) was used to measure the quality of  sequencing. 
Figure 6. Increased GC B cell apoptosis in TFR-deficient mice. WT, 
Bcl6FC, Blimp1FC, and DKO mice were immunized with SRBCs and 
spleen cells were analyzed by flow cytometry for B220+CD38–GL7+ 
GC B cells. (A) Representative flow plots are shown. (B and C) The 
relative decrease of GC B cells in Bcl6FC and DKO mice is graphed 
with (C) Bcl6FC mice compared with WT mice, and (D) DKO mice 
compared with Blimp1FC mice. GC B cell percentages were normal-
ized to average control (WT in B, Blimp1FC in C) GC B cell percent-
ages. Individual GC B cell gain or decrease was determined by the 
following formula: ([average control % – normalized individual %]/
average control %) × 100, with a positive value equaling loss and a 
negative value equaling gain. n = 8; data in B and C are combined 
from 2 different experiments. Student’s t test was used to detect 
significant differences. (D) Annexin V+ GC B cells in WT, Bcl6FC, 
Blimp1FC, and DKO mice, 3 days after immunization. Flow plots 
show GC B cells gated as in A. Graphs show average annexin V+ GC 
B cells. n = 4; experiment was repeated 3 times; representative 
data are shown. ANOVA with Tukey’s post hoc analysis was used 
to test for significant differences.
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More than 90% of  the sequencing reads reached Q30 (99.9% base call accuracy). For sequence alignment 
and gene counts, the sequencing data were first assessed using FastQC (Babraham Bioinformatics) for qual-
ity control. Then all sequenced libraries were mapped to the mouse genome (mm10) using STAR RNA-
seq aligner with the parameter “--outSAMmapqUnique 60.” The reads distribution across the genome 
was assessed using bamutils (from ngsutils). Uniquely mapped sequencing reads were assigned to mm10 
refGene genes using featureCounts (from subread) with the parameters “-s 2 –p –Q 10.” Quality control 
of  sequencing and mapping results was summarized using MultiQC. Genes with read count per million 
(CPM) less than 0.5 in more than 4 of  the samples were removed. The data were normalized using the 
trimmed mean of  M values (TMM) method. Differential expression analysis was performed using edgeR. 
False discovery rate (FDR) was computed from P values using the Benjamini-Hochberg procedure. DEGs 
were determined if  their P values were less than 0.05 after multiple-test correction with FDR adjustment 
and the amplitudes of  fold changes (FCs) were larger than 1.8. RNAseq data were submitted to the NCBI 
Gene Expression Omnibus under accession number GSE133533.
Statistics. Flow cytometry and qPCR data analysis was done using GraphPad Prism software. Graph 
bars represent the mean ± SEM. Unless otherwise stated, Student’s t test (2-tailed) or ANOVA with Tukey’s 
post hoc analysis were used to determine significance. Significant differences (P < 0.05) are indicated in the 
figures. In order to examine the statistical significance of  overlap between 2 sets of  genes, we calculated the 
P value based on hypergeometric distribution.
Study approval. Mice were handled according to protocols approved by the IUSM Institutional Animal 
Use and Care Committee (IACUC).
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